Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target […]
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have earned a consensus rating of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target […]
